T. Rowe Price Associates
SBBP

T. Rowe Price Associates’s Strongbridge Biopharma plc. SBBP Stock Holding History

T. Rowe Price Associates’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-36,100
Closed -$74K – 3110
2021
Q3 		$74K Hold
36,100
– – ﹤0.01% 2882
2021
Q2 		$107K Sell
36,100
-2,851
-7% -$7.53K ﹤0.01% 2839
2021
Q1 		$108K Buy
+38,951
New +$118K ﹤0.01% 2775

T. Rowe Price Associates's SBBP Position: Q4 2021 in Review

T. Rowe Price Associates sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 36,100 shares — an estimated $74K sold.

T. Rowe Price Associates first reported a position in SBBP in Q1 2021 and held it in 3 quarters. The position peaked at $108K in Q1 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

  • T. Rowe Price Associates reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 36,100 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $74K.
  • T. Rowe Price Associates first reported a position in Strongbridge Biopharma plc. in Q1 2021 and held it in 3 quarters.
  • T. Rowe Price Associates's Strongbridge Biopharma plc. position peaked at $108K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.